Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

被引：0
|
作者：
Rasmussen, Birgitte B. [1 ]
Ejlertsen, Bent [1 ]
Nielsen, Kirsten Vang [2 ]
Balslev, Eva [1 ]
Muller, Sven [2 ]
Moller, Susanne [1 ]
Mouridsen, Henning T. [1 ]
机构：
[1] DBCG, Copenhagen, Denmark
[2] Dako AS, Glostrup, Denmark
来源：
APMIS | 2008年 / 116卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：248 / 249
页数：2
相关论文
共 50 条
  • [1] Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer
    Kirsten Vang Nielsen
    Bent Ejlertsen
    Sven Müller
    Susanne Møller
    Birgitte B. Rasmussen
    Eva Balslev
    Anne-Vibeke Lænkholm
    Peer Christiansen
    Henning T. Mouridsen
    Breast Cancer Research and Treatment, 2011, 127 : 345 - 355
  • [2] Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer
    Nielsen, Kirsten Vang
    Ejlertsen, Bent
    Muller, Sven
    Moller, Susanne
    Rasmussen, Birgitte B.
    Balslev, Eva
    Laenkholm, Anne-Vibeke
    Christiansen, Peer
    Mouridsen, Henning T.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (02) : 345 - 355
  • [3] Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer
    Ejlertsen, B.
    Nielsen, K., V
    Rasmussen, B. B.
    Balslev, E.
    Muller, S.
    Moller, S.
    Mouridsen, H. T.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S34 - S34
  • [4] Estrogen receptor α gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients
    Tomita, Saori
    Zhang, Zhenhuan
    Nakano, Masahiro
    Ibusuki, Mutsuko
    Kawazoe, Teru
    Yamamoto, Yutaka
    Iwase, Hirotaka
    CANCER SCIENCE, 2009, 100 (06): : 1012 - 1017
  • [5] Implications of ESR1 Mutations in Hormone Receptor-Positive Breast Cancer
    Tomás Reinert
    Rodrigo Gonçalves
    José Bines
    Current Treatment Options in Oncology, 2018, 19
  • [6] Implications of ESR1 Mutations in Hormone Receptor-Positive Breast Cancer
    Reinert, Tomas
    Goncalves, Rodrigo
    Bines, Jose
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (05)
  • [7] Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer
    Lippman, Marc
    LANCET ONCOLOGY, 2019, 20 (03): : 312 - 313
  • [8] Overexpression of Notch-1 induced tamoxifen resistance through down regulation of ESR1 in positive estrogen receptor breast cancer
    Yousif, Nasser Ghaly
    Al-Matwari, Majid
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] On the evidence for ESR1 amplification in breast cancer
    Frederik Holst
    Cathy B. Moelans
    Martin Filipits
    Christian F. Singer
    Ronald Simon
    Paul J. van Diest
    Nature Reviews Cancer, 2012, 12 : 149 - 149
  • [10] On the evidence for ESR1 amplification in breast cancer
    Holst, Frederik
    Moelans, Cathy B.
    Filipits, Martin
    Singer, Christian F.
    Simon, Ronald
    van Diest, Paul J.
    NATURE REVIEWS CANCER, 2012, 12 (02) : 149 - 149
12345